Site Search | NIAMS

Displaying 141 - 160 of 210 results

Exploratory Clinical Trial Grants (R61)

https://www.niams.nih.gov/grants-funding/conducting-clinical-research/exploratory-grants

The Exploratory Clinical Trial Grant Program fosters the development and implementation of interventional exploratory clinical trials aimed at providing clinically meaningful improvements in symptoms, function or disease course for patients with rheumatic, musculoskeletal or skin diseases. The trials must address research questions related to the mission and goals of the

NIAMS Advisory Council Agenda

https://www.niams.nih.gov/about/working-groups/advisory-council/working-groups/advisory_council_agenda

This page provides the latest NIAMS Advisory Council Meeting agenda.

Wellstone Muscular Dystrophy Research Network

https://www.niams.nih.gov/grants-funding/wellstone-muscular-dystrophy-research-network

The Wellstone Centers seek to promote collaborative basic, translational, and clinical research and provide important resources that can be used by muscular dystrophy researchers.

Colbert Selected to Lead NIAMS Clinical Research Program

https://www.niams.nih.gov/newsroom/announcements/colbert-selected-lead-niams-clinical-research-program

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) appointed Robert A. Colbert, M.D., Ph.D., as the director of the Institute's Clinical Research Program on February 16, 2020. Colbert, who joined the NIAMS in 2008, had served as deputy clinical director since 2012 and as acting clinical director since June 2018. "What excites me about the NIAMS Clinical Research Program director position is the opportunity we have to make an impact," Colbert explained. "We have a number of research programs that are making new discoveries that reveal how diseases develop and evolve and are translating these discoveries into

Coping with the COVID-19 Pandemic

https://www.niams.nih.gov/about/about-the-director/letter/Coping-with-the-COVID-19-Pandemic

There’s no doubt that the global COVID-19 pandemic has upended our daily lives in unprecedented ways. This crisis has imposed unique challenges for people from all walks of life. I want to take a moment to acknowledge the strength, adaptability and resolve of the entire NIAMS community as we navigate this unpredictable situation.

Drugs treat spinal disc degeneration in mice

https://www.niams.nih.gov/drugs-treat-spinal-disc-degeneration-mice

A research team led by Dr. Makarand Risbud of Thomas Jefferson University tested whether treatment with the drugs dasatinib and quercetin would prevent disc degeneration in mice. Both drugs are senolytics, which selectively remove aged cells known as senescent cells.

Hairy human skin generated from stem cells

https://www.niams.nih.gov/hairy-human-skin-generated-stem-cells

Skin is the body’s largest organ and plays a vital role in health. It helps regulate body temperature, retain body fluid, and defend against the outside world. It also allows the sensation of touch and pain. Skin is a complex structure made up of multiple layers. It contains fat, nerves, glands, and hair follicles. Scientists have been able to grow human skin outside the body for over 40 years. However, skin grown in cultures lacked embedded structures, like hair follicles and sweat glands, found in real skin. A team of researchers led by Dr. Karl Koehler of Boston Children’s Hospital

골다공증 (Osteoporosis)

https://www.niams.nih.gov/health-topics/osteoporosis

What is osteoporosis? It is a disease in which your bones become weak and are more likely to break. There are no symptoms until a bone breaks.

Accelerating Medicines Partnership® Autoimmune and Immune-Mediated Diseases (AMP® AIM) Program

https://www.niams.nih.gov/grants-funding/niams-supported-research-programs/accelerating-medicines-partnership-amp

The Accelerating Medicines Partnership® Autoimmune and Immune-Mediated Diseases (AMP® AIM) program launched in 2021 with the goal of deepening our understanding of the cellular and molecular interactions that lead to inflammation and autoimmune diseases.

Osteoporosis

https://www.niams.nih.gov/health-topics/osteoporosis

What is osteoporosis? It is a disease in which your bones become weak and are more likely to break. There are no symptoms until a bone breaks.

Bone Health and Osteoporosis

https://www.niams.nih.gov/health-topics/bone-health-and-osteoporosis

Why does bone health matter? Learn more about what you can do to help keep your bones strong and healthy, what the risk factors are for osteoporosis, and how to live well if you have osteoporosis.

FY 2018 Funding Plan

https://www.niams.nih.gov/about/budget/fy2018

August 27, 2018 NIAMS FY 2018 Enacted Level: $586,661,000 The NIAMS is operating under the FY 2018 Omnibus Appropriations bill. The funding plan below for research and training grants represents the most current information as of the date cited above; however, many factors occurring throughout the fiscal year can affect

The Stephen I. Katz Early Stage Investigator Research Grant Program

https://www.niams.nih.gov/grants-funding/applying-grant/grant-review-process/stephen-i-katz-early-stage-investigator-research

Dr. Stephen I. Katz directed the National Institute of Arthritis and Musculoskeletal and Skin Diseases from August 1995 until his death in December 2018. He is remembered as an outstanding scientist, administrator, and civil servant who was committed to excellence, transparency, integrity, and public trust. But perhaps most noteworthy were

Letter from the Director: Beginning a New Chapter in the NIAMS Story: Moving Ahead as a Community

https://www.niams.nih.gov/about/about-the-director/letter/letter-director-beginning-new-chapter-niams-story-moving-ahead

Every great journey starts with a single step. As I embark on my new role as the director of the NIAMS, I am ready to listen and learn from the entire NIAMS community. I am honored to be starting such an important role.

FY 2015 Congressional Justification

https://www.niams.nih.gov/about/budget/fy2015/congressional-justification

March 2014 Organization Chart View a larger version of the organization chart. Top Appropriation Language NATIONAL INSTITUTES OF HEALTH National Institute of Arthritis and Musculoskeletal and Skin Diseases For carrying out section 301 and title IV of the PHS Act with respect to arthritis and musculoskeletal and skin diseases, [$520,053,000]

Bệnh Gout (Gout)

https://www.niams.nih.gov/health-topics/gout

Gút là một trong những dạng viêm khớp gây đau đớn nhất. Bệnh gút xảy ra khi có quá nhiều axit uric tích tụ trong cơ thể.

FY 2017 Funding Plan

https://www.niams.nih.gov/about/budget/fy2017/funding-plan

The NIAMS provides the 2017 interim funding plan for research and training grants.

FY 2016 Funding Plan

https://www.niams.nih.gov/about/budget/fy2016/funding-plan

The NIAMS provides the 2016 interim funding plan for research and training grants. The NIAMS is operating under the FY 2016 Omnibus Appropriations bill. The funding plan below for research and training grants represents the most current information as of the date cited above; however, many factors occurring throughout the fiscal year can affect the operating policies, thus they are subject to change.

FY 2015 Funding Plan

https://www.niams.nih.gov/about/budget/fy2015/funding-plan

The NIAMS is operating under the Consolidated and Further Continuing Appropriations Act of 2015. The funding plan below for research and training grants represents the most current information as of the date cited above; however, many factors occurring throughout the fiscal year can affect the operating policies, thus they are subject to change.

New NIH Research Grants Honor Legacy of Former NIAMS Director Stephen I. Katz, M.D., Ph.D.

https://www.niams.nih.gov/about/about-the-director/letter/new-nih-research-grants-honor-legacy-of-former-niams-director

We at NIAMS are excited as we look forward to the arrival of Lindsey Criswell as the new Director but our thoughts also turn back to memories of our previous Director, Steve Katz. He was a unique voice who guided the NIAMS as director for more than two decades and who spent his career mentoring the next generations of researchers. With this in mind, I am pleased to share news of new awards that give the NIH a unique way to encourage the scientists of tomorrow.